文献速递糖尿病

1型糖尿病成人使用糖尿病技术时低血糖恐惧与感知频率及CGM指标的相关性:1年分析

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A 1-Year Analysis.
PubMed 文献 · Diabetes Care · 2026-01-01

本研究回顾性分析1370例使用实时CGM或混合闭环系统的1型糖尿病成人,评估低血糖恐惧(HFS-worry/behavior)和感知低血糖频率(DTSQs-hypo)与CGM指标在12个月内的相关性。结果显示12个月内低血糖时间减少,恐惧和感知频率也下降,但两者与CGM指标均无明确相关性。提示低血糖恐惧和感知频率受血糖谱之外因素影响。

要点

  • 使用糖尿病技术的1型糖尿病成人中,低血糖恐惧和感知频率与CGM指标无明确相关性。
  • 12个月内低血糖时间(<3.9/<3.0 mmol/L)从3.4±3.5%/0.8±1.4%降至2.3±2.2%/0.5±0.7%。
  • 低血糖恐惧和感知频率可能受血糖谱之外的因素影响。

核心结论

  • 在成人1型糖尿病使用糖尿病技术12个月中,低血糖恐惧和感知频率与CGM指标无明确相关性,提示二者受血糖谱之外因素影响。

研究设计与样本

  • 回顾性探索性分析,纳入1370例成人1型糖尿病患者,使用实时CGM(ALERTT1研究,n=254)或混合闭环(INRANGE研究,n=1,116)12个月。
  • 低血糖恐惧采用低血糖恐惧调查II担忧(HFS-worry)和行为(HFS-behavior)子量表评估,感知低血糖频率采用糖尿病治疗满意度问卷状态版低血糖子量表(DTSQs-hypo)评估。

主要发现

  • 基线时平均年龄41.0±13.7岁,女性55.9%,糖尿病病程21.6±12.7年,HbA1c 7.6±1.0%(59.0±10.8 mmol/mol),时间在3.9-10.0 mmol/L为61.1±15.5%。
  • 12个月内,时间<3.9/<3.0 mmol/L从3.4±3.5%/0.8±1.4%降至2.3±2.2%/0.5±0.7%,HFS-worry从21.0±12.9降至16.8±12.1,DTSQs-hypo从3.3±1.5降至2.7±1.4。
  • HFS-worry、HFS-behavior和DTSQs-hypo在基线、12个月时及12个月变化中与低血糖时间或其他CGM指标均无明确相关性。

临床怎么用

  • 临床中不能仅凭CGM指标推断患者的低血糖恐惧或感知频率,需结合心理评估工具识别。

局限性

  • 本研究为回顾性探索性分析,仅提示相关性,不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between fear and perceived frequency of hypoglycemia and continuous glucose monitoring (CGM) metrics in adults with type 1 diabetes using diabetes technology over 12 months. RESEARCH DESIGN AND METHODS: This retrospective explorative analysis evaluated correlations between hypoglycemia fear, perceived hypoglycemia frequency, and CGM metrics in 1,370 adults with type 1 diabetes using real-time CGM (Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes [ALERTT1] study, n = 254) or hybrid closed-loop (The Impact of Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs [INRANGE] studies, n = 1,116) for 12 months. Hypoglycemia fear was assessed with the Hypoglycemia Fear Survey II worry (HFS-worry) and behavior (HFS-behavior) subscales and perceived hypoglycemia frequency with the hypoglycemia subscale of the Diabetes Treatment Satisfaction Questionnaire-status (DTSQs-hypo). Data are reported as mean ± SD. RESULTS: At baseline (before the start of technology), mean age was 41.0 ± 13.7 years, 55.9% were women, diabetes duration was 21.6 ± 12.7 years, HbA1c was 7.6 ± 1.0% (59.0 ± 10.8 mmol/mol), and time in 3.9-10.0 mmol/L was 61.1 ± 15.5%. Over 12 months, time <3.9/<3.0 mmol/L decreased from 3.4 ± 3.5%/0.8 ± 1.4% to 2.3 ± 2.2%/0.5 ± 0.7%, while HFS-worry (21.0 ± 12.9 to 16.8 ± 12.1) and DTSQs-hypo (3.3 ± 1.5 to 2.7 ± 1.4) also decreased. HFS-worry, HFS-behavior, and DTSQs-hypo showed no clear correlations with time in hypoglycemia or other CGM metrics at baseline, at 12 months, or over 12-month change. CONCLUSIONS: In adults using diabetes technology over 12 months, fear and perceived frequency of hypoglycemia showed no clear correlations with CGM metrics, suggesting both are influenced by more than glycemic profiles alone.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Valgaerts L, De Meulemeester J, Visser MM, et al. The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A 1-Year Analysis. Diabetes Care. 2026. PMID: 42406897. doi:10.2337/dc26-0763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。